Weight Loss Drugs Changed Their Lives. Then They Lost Coverage.
The letter came in June. Mindy McCormick, 67, read that her insurer would soon stop covering the weight loss drug Wegovy, which she had been taking for more than two years. What? she remembers thinking.
Weight loss drugs could help end obesity - but risks remain, WHO says
A new class of weight loss drugs developed by Novo Nordisk and Eli Lilly “opens the possibility of an end to the obesity pandemic” alongside other interventions, the World Health Organization (WHO) said this week.
Weight loss drugs help with fat loss – but they cause bone and muscle loss too
Up to a third of the weight lost while taking weight loss jabs such as Wegovy and Mounjaro includes muscle and bone mass.
What's ahead for weight loss drugs in 2025, according to Noom's CEO
Quartz spoke with Noom CEO Geoff Cook to get his take on what 2025 holds for the compounded drug market and the overall future of weight-loss drugs. Cook took over as CEO of the psychology-based weight loss app Noom in 2023,
Weight-loss drugs draw Americans back to the doctor
Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with obesity-related conditions or take the drugs to become eligible for other services,
Pricey weight loss drugs lose some disciples in 2024
People struggling with their body weight experienced joy when new, more effective prescription drug options became the rage in 2023, but it seems many folks stopped taking them in 2024.
Holidays on weight-loss drugs: A relief for some, 'sad' and difficult for others
Part of the joy of the season may be gone — or feel different — for people who are taking popular weight-loss drugs and can't eat as much as before.
FDA declares shortage over for popular weight-loss, diabetes drugs
The FDA declared a shortage of popular weight-loss and diabetes drugs. Here's what that means for people who get generic versions of Mounjaro or Zepbound.
Lubbock doctor offers advice on using weight loss drugs
Dr. Drew Payne, a Texas Tech Physician who specializes in weight loss strategies, has some advice about trying weight loss drugs in the new year.
How Weight-Loss Drugs Add to Anorexia’s Dangers
Telehealth companies looking to capitalize off the weight-loss drug boom have made it as seamless as possible to get the shots, sometimes regardless of medical need.
MIT Technology Review2d
The Download: shaking up neural networks, and the rise of weight-loss drugs
Scientists have known for years that light pollution is growing and can harm both humans and wildlife. In people, increased ...
Yahoo3d
IL Attorney General urges residents be vigilant when seeking weight loss drugs
These compounded drugs are not the same as generic drugs because they are ... The FDA has issued warnings to try to stop ...
Novo Nordisk stock plunges 20% after a trial of its latest weight loss drug disappoints
The Ozempic maker's stock tanked after its highly anticipated CagriSema drug trial showed an average of 22.7% weight loss, ...
CNET2d
What to Know About Ozempic, Wegovy and the New Weight-Loss Market
Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new ...
An experimental drug drove people to lose 23% of their body weight. It’s still seen as a disappointment
Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...
In weight loss battle, Novo and Lilly face growing offensive from licensed copies
As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented ...